All News about Sage Therapeutic Com
![](https://mms.businesswire.com/media/20220429005707/en/1438772/5/Biogen_Logo_Standard.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3645.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220413005785/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/red-blood-cell-gc6575ac93_1920_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6011.jpeg?width=1200&height=800&fit=crop)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_5162.jpeg?width=720)
![](https://cdn.benzinga.com/files/images/story/2012/biotech6_1.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://mms.businesswire.com/media/20220331006048/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5926.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220321005602/en/736779/5/Sage_logo.jpg)
Sage Therapeutics to Present at 2022 Stifel CNS Days
March 22, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220314005820/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_3566.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-gdd37bc5d2_1920_13.jpg)
![](https://mms.businesswire.com/media/20220223006370/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech7.jpg)
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-sagetherapeutics-02-shutt.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2724.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_394.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_122.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3537.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://mms.businesswire.com/media/20220215006261/en/1361548/5/Sage_Lock-up_Primary_BType_RGB_R.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220209005802/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/dsc06532_6.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220103005480/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nik-shuliahin-bunwp1bl0nc-unsplash_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/valuestock_image_590.jpeg)
![](https://mms.businesswire.com/media/20211213006006/en/736779/5/Sage_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.